Get started
Author

László E. Kiss

Observed names: Kiss, László E, Kiss, László E., L. E. KISS, Laszlo E. Kiss, László KISS
Institution: Bial (Portugal)
ORCID: 0000-0003-1306-8752
Observed ORCID: 0000-0003-1306-8752
OpenAlex ID: A5081620292
Discovery of a Long-Acting, Peripherally Selective Inhibitor of Catechol-O-methyltransferase
2010 · László E. Kiss, Humberto S. Ferreira, et al. · Journal of Medicinal Chemistry · 168
An improved design of fluorophilic molecules: prediction of the ln P fluorous partition coefficient, fluorophilicity, using 3D QSAR descriptors and neural networks
2001 · László E. Kiss, István Kövesdi, et al. · Journal of Fluorine Chemistry · 109
Medicinal Chemistry of CatecholO-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility
2014 · László E. Kiss, Patrício Soares-da-Silva · Journal of Medicinal Chemistry · 104
Efficient Synthesis of 2-(Trifluoromethyl)nicotinic Acid Derivatives from Simple Fluorinated Precursors
2008 · László E. Kiss, Humberto S. Ferreira, et al. · Organic Letters · 49
Design, synthesis, and structure–activity relationships of 1,3,4-oxadiazol-2(3H)-ones as novel FAAH inhibitors
2011 · László E. Kiss, Humberto S. Ferreira, et al. · MedChemComm · 28
Discovery of a Potent, Long‐Acting, and CNS‐Active Inhibitor (BIA 10‐2474) of Fatty Acid Amide Hydrolase
2018 · László E. Kiss, Alexandre Beliaev, et al. · ChemMedChem · 25
PDF
The Chemistry of Catechol-O-Methyltransferase Inhibitors
2010 · David A. Learmonth, László E. Kiss, et al. · International review of neurobiology · 20
Methyl Perfluorooctanethionate as a Tool for Indirect Perfluoroalkylmethylation and Perfluoroalkylation of Amines
1998 · László E. Kiss · Synlett · 20
Catechol‐O‐Methyl‐Transferase Inhibitors: Present Problems and Relevance of the New Ones
2013 · P. Nuno Palma, László E. Kiss, et al. · Royal Society of Chemistry eBooks · 16
Absorption, metabolism and excretion of opicapone in human healthy volunteers
2022 · Ana I. Loureiro, Francisco Rocha, et al. · British Journal of Clinical Pharmacology · 9
PDF
Metabolism and disposition of opicapone in the rat and metabolic enzymes phenotyping
2021 · Ana I. Loureiro, Carlos Fernandes‐Lopes, et al. · Pharmacology Research & Perspectives · 4
Synthesis and structure–activity relationships of ionizable 1,3,4-oxadiazol-2(3H)-ones as peripherally selective FAAH inhibitors with improved aqueous solubility
2016 · Alexandre Beliaev, Humberto S. Ferreira, et al. · Pure and Applied Chemistry · 4
PDF
Metabolism and disposition of zamicastat in rats
2024 · Francisca Araújo, Maria Luisa Dória, et al. · Xenobiotica · 2
Human metabolism of zamicastat, an oral dopamine β-hydroxylase inhibitor
2025 · Ana Isabel Loureiro, Franscisca Araújo, et al. · Drug Metabolism and Disposition · 1
Estimation of the Usefulness of Glassy Carbon Electrode in Non-aqueous Solvents Polarized to Higher Anodic Potentials
2020 · László KISS, Sándor KUNSÁGI-MÁTÉ · Studia Universitatis Babeș-Bolyai Chemia · 1
PDF
Opicapone, a Novel Catechol‐O‐Methyltranferase Inhibitor ( COMT ) to Manage the Symptoms of P arkinson's Disease
2018 · László E. Kiss, Maria João Bonifácio, et al. · Wiley eBooks · 1
ChemInform Abstract: Methyl Perfluorooctanethionate as a Tool for Indirect Perfluoroalkylmethylation and Perfluoroalkylation of Amines.
1999 · L. E. KISS, J. RABAI, et al. · ChemInform
Works count: 20
Citation count: 563
H-index: 9
I10-index: 9
Year
Topic
Type